470
Views
15
CrossRef citations to date
0
Altmetric
Original Article

An evaluation of the initial and long‐term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension

Pages 13-18 | Published online: 08 Jul 2009

References

  • Brown B., Hall A. S. Renin–angiotensin system modulation; The weight of evidence. Am J Hypertens 2005; 18: 127S–133S
  • The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Blood Press 2007; 16: 135–232
  • Niskanen L., Hedner T., Hansson L., Lanke J., Niklason A., CAPPP Study Group. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first‐line therapy with an ACE inhibitor compared with a diuretic/beta‐blocker‐based treatment regimen: A subanalysis of the Captopril Prevention Project. Diabetes Care 2001; 24: 2091–2096
  • Hansson L., Lindholm L. H., Niskanen L., Lanke J., Hedner T., Niklason A., et al. Effect of angiotensin‐converting‐enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611–616
  • Niklason A., Hedner T., Niskanen L., Lanke J., Captopril Prevention ProjectStudy Group. Development of diabetes is retarded by ACE inhibition in hypertensive patients – a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens 2004; 22: 645–652
  • Mancia G., Grassi G., Zanchetti A. New‐onset diabetes and antihypertensive drugs. J Hypertens 2006; 24: 3–10
  • Julius S., Kjeldsen S. E., Weber M., Brunner H. R., Ekman S., Hansson L., , for the VALUE trial group, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine the VALUE randomised trial. Lancet 2004; 363: 2022–2031
  • Arakawa S., Saku Y., Ibayashi S., Nagao T., Fujishima M. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998; 29: 1806–1809
  • Svensson S., Kjellgren K. I., Ahlner J., Saljo R. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000; 76: 157–163

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.